Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma

This study highlights Paromomycin's potential as a therapeutic agent for GBM by targeting HDAC1-mediated SUMOylation pathways and influencing IGF1R translocation, warranting further investigation for its clinical application.

Authors

Min Zhong (ORCID: https://orcid.org/0000-0002-0301-8324)
Yuejie Guo
Ning Luo

Institutions

Chenzhou First People's Hospital (CN)

Publication Details

Journal: Frontiers in Pharmacology
Published: 2024-12-11
DOI: https://doi.org/10.3389/fphar.2024.1490878
Citations: 3
Primary Topic: Histone Deacetylase Inhibitors Research
Type: article
Field-Weighted Citation Impact: 0.70

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma

Min Zhong, Yuejie Guo, Ning Luo

Dec 11, 2024

3 citations

Frontiers in Pharmacology

Histone Deacetylase Inhibitors Research

0.70

article

Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma

Min Zhong, Yuejie Guo, Ning Luo

December 11, 2024article en

3 citations

Abstract

Frontiers in PharmacologyVol. 15

Chenzhou First People's Hospital (CN)

Openalex Percentile: Top 28%

Histone Deacetylase Inhibitors Research

0.70

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma — Min Zhong, Yuejie Guo, et al. · Frontiers in Pharmacology (2024) | TGRS Research Map | TGRS